Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Sami Corwin’s rating is based on several strategic factors that highlight PTC Therapeutics’ potential ...

WARREN, N.J., Nov. 26, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the global Phase 2 placebo-controlled CardinALS study did not meet its primary endpoint of ...

In other recent news, PTC Inc. reported a strong finish for fiscal year 2024, with significant increases in key financial metrics and strategic realignments. The company's free cash flow rose by ...

With the fiscal year ending on September 30, this board change marks a notable shift in PTC's governance as it continues its operations headquartered at 121 Seaport Boulevard, Boston, Massachusetts.

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

WARREN, N.J., Nov. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 20, 2024, the company approved non-statutory stock options to purchase an aggregate ...

This cost is determined by the supplier contract or, for those who have not shopped around, the utility’s “Price to Compare” ...

Raymond James analyst Danielle Brill maintained a Buy rating on PTC Therapeutics (NASDAQ:PTCT) on Thursday, setting a price target of $63, which is approximately 16.90% above the... RBC Capital ...